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A B S T R A C T
Myocarditis and acute coronary syndrome are both described in the setting of concurrent
hypersensitivity reactions to a variety of allergenic triggers (hypersensitivity myocarditis and Kounis
syndrome respectively). Mast cell degranulation is thought to be pivotal in the pathogenesis of both
clinical entities. Cardiac magnetic resonance imaging (CMR) has assumed a key role in the assessment of
chest pain syndromes, providing a useful non-invasive tool to aid clinical decision-making. Despite
increasing availability and uptake of CMR, only a small fraction of published Kounis syndrome cases
report CMR ﬁndings, and conﬁrmation of myocardial infarction remains elusive. We present a case of
presumed Kounis syndrome with comprehensive CMR imaging that provides an insight into why these
two well-described clinical entities share many clinical features – perhaps they are one and the same.
<Learning objective: Myocarditis and acute coronary syndrome (ACS) in the setting of hypersensitivity
reactions share similar clinical characteristics. Endomyocardial biopsies are often not undertaken in this
patient group, and differentiation has typically been at the clinicians’ discretion. Cardiac magnetic
resonance imaging can provide an insight into the underlying pathogenesis, with currently available
evidence suggesting myocarditis is a prerequisite for ACS, rather than being stand-alone clinical
entities.>
Crown Copyright  2015 Published by Elsevier Ltd on behalf of Japanese College of Cardiology. All rights
reserved.
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Myocarditis and acute coronary syndrome are both described in
the setting of concurrent hypersensitivity reactions to a variety of
allergenic triggers. Mast cell degranulation is thought to be pivotal in
the pathogeneses of both clinical entities – the former resulting in
myocardial inﬂammation and the latter in coronary artery vaso-
spasm, allergic myocardial infarction, or stent thrombosis (Kounis
syndrome variants I, II, and III respectively). Clinical presentation,
electrocardiograph (ECG) changes, and biochemical markers are
virtually identical in both descriptions. It is recommended that
patients presenting with any grade of systemic allergic reaction
associated with clinical, laboratory, and ECG evidence of myocardial
ischemia be diagnosed with Kounis syndrome [1].
Since Kounis syndrome was ﬁrst described in 1991 [1] there
have been signiﬁcant advancements in both cardiac magnetic* Corresponding author at: CVIU, Level 6 Theatre Block, Royal Adelaide Hospital,
Adelaide, SA, Australia. Tel.: +61 8 8222 4000; fax: +61 8 8222 2587.
E-mail address: Baillie.tim@gmail.com (T.J. Baillie).
http://dx.doi.org/10.1016/j.jccase.2015.05.012
1878-5409/Crown Copyright  2015 Published by Elsevier Ltd on behalf of Japanese Cresonance imaging (CMR) technology and accessibility, which now
assumes a key role in the non-invasive diagnosis of acute
myocarditis, and more widely in the assessment of undifferentiat-
ed chest pain syndromes. Despite these advances and mounting
case reports in the literature, there remains a paucity of CMR data
in Kounis syndrome. To date, three cases fulﬁlling clinical criteria
for Kounis syndrome have reported CMR imaging. Two cases were
consistent with hypersensitivity myocarditis rather than myocar-
dial infarction, one of which was proven on endomyocardial biopsy
[2,3]. The third case cited tapering myocardium, hypokinesis in the
distal inferior wall and apex, and a small pericardial effusion as
evidence of myocardial ischemia, all features that could – and are
more likely to – reﬂect myocarditis, particularly in the absence of
late gadolinium enhancement (LGE), an elevated troponin level, or
abnormal ECG ﬁndings [4]. Surprisingly there are no cases of
Kounis syndrome with objective evidence of isolated myocardial
ischemia or infarction. Our case presentation, CMR ﬁndings, and
subsequent literature review provide an insight into why these
two clinical entities are often inseparable – perhaps they are one
and the same.ollege of Cardiology. All rights reserved.
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A 58-year-old man presented to the emergency department
with inﬂuenza-like symptoms, dizziness, chest pain, dyspnea, and
an erythematous rash. Cardiovascular risk factors included
hypertension and hypercholesterolemia. He was hypotensive
(blood pressure 85/45 mmHg), tachycardic, and hypoxic (SaO2
82–84%). An ECG showed ST segment elevation in the inferior leads
with reciprocal ST depression in V1, V2, and aVL (Fig. 1). He was
taken for emergency cardiac catheterization that revealed only
mild (20%) proximal right coronary artery stenosis without
evidence of ruptured vulnerable plaque or vasospasm. Left
coronary arteries were angiographically smooth and systolic
function on left ventriculogram was normal (ejection frac-
tion = 74%). Blood tests subsequently revealed an elevated tropo-
nin T that peaked at 681 ng/ml (normal <0.1 ng/ml).
Prior to his presentation, he reported a nine-day history of an
inﬂuenza-like illness for which he consulted his general practi-
tioner, who prescribed amoxicillin with clavulanic acid. His
symptoms began abruptly after taking the ﬁrst dose, having
completed a course of the same antibiotic without incident three
weeks earlier. Initial serum tryptase level was elevated at 111 mg/L
(normal <12 mg/L), normalizing by day three. Subsequent allergen
speciﬁc IgE was positive to penicilloyl G (6.7 kU/L), penicilloyl V
(91.5 kU/L), and amoxicilloyl (49 kU/L), consistent with an
immediate hypersensitivity reaction to amoxicillin. Full blood
examination and biochemistry were unremarkable. The clinical
presentation, ECG, coronary angiogram, and blood work ﬁndings
were consistent with a diagnosis of type I Kounis syndrome. He
remained stable throughout his admission without symptoms or
signs of heart failure.
CMR imaging was performed on the fourth day to evaluate the
etiology of myocardial necrosis, and speciﬁcally to assess for
evidence of myocarditis or myocardial infarction. This showed
overall normal left ventricular systolic function (ejection frac-
tion = 61%) with hypokinetic mid to distal inferior wall segments.
Contrast agent was administered (0.15 mmol/kg Gd-DTPA; Mag-
nivist; Schering AG, Berlin, Germany) with evidence of early
gadolinium enhancement (EGE) and myocardial edema in these
regions. Delayed imaging was performed after 10 min, showing
transmural late gadolinium enhancement (LGE) in the distalFig. 1. Presenting electrocardiogram showing inferior ST elevation with reciprocal inferior wall, with patchy mid-wall and sub-epicardial LGE in
adjacent segments (Fig. 2). Repeat CMR three months later showed
normal left ventricular systolic function, resolution of edema and
EGE, but persistence of transmural and subepicardial LGE in the
distal inferior wall (Fig. 2). These ﬁndings were suggestive of both
myocarditis (subepicardial and mid-wall LGE) and myocardial
infarction (subendocardial LGE extending transmurally).
Discussion
Kounis syndrome has been deﬁned as ‘‘the coincidental
occurrence of chest pain and allergic reactions accompanied by
clinical and laboratory ﬁndings of classical angina pectoris caused
by inﬂammatory mediators released during the allergic insult’’
[1]. More than 300 cases of Kounis syndrome have been reported in
the literature without racial or age predilection, and in response to
a variety of allergens. Degranulation of mast cells and release of
inﬂammatory mediators such as histamine, tryptase, serotonin,
and leukotrienes are postulated to promote the coronary artery
vasospasm thought to underlie type I variant Kounis syndrome,
although causation has not been established in humans or
experimental models [1]. An elevated serum tryptase level was
evidence of mast cell activation in our patient.
Like Kounis syndrome, a variety of allergens have been
implicated in hypersensitivity myocarditis, the most common
cause of acute medication-related myocardial injury [2]. Rather
than predominantly affecting the coronary arteries as postulated in
Kounis syndrome, the allergic reaction manifests as myocardial
inﬂammation with or without pericardial and conduction system
involvement [3]. Myocardial inﬂammation of any cause has been
known to mimic acute coronary syndrome (ACS). For example,
endomyocardial biopsies of 24 consecutive patients with sus-
pected ACS but normal coronary arteries showed evidence of viral
genomes in 71% of cases, suggesting myocarditis as the cause
[5]. Sarda and colleagues showed 40% of 45 patients presenting
with presumed ACS but normal coronary arteries had scintigraphic
evidence of focal or heterogenous myocarditis [6]. Furthermore,
Yilmaz et al. provoked coronary vasospasm with intracoronary
acetylcholine in 71% of patients presenting with atypical chest pain
and biopsy-proven myocarditis, compared with 40% of patients
with similar symptoms but normal biopsy results, suggestingdepression.
Fig. 2.
Subendocardial late gadolinium enhancement (LGE) extending transmurally, and mid-wall/subepicardial LGE on day 4 (a, b, c), and at three months (d, e, f).
Vertical arrows highlight subendocardial LGE more typical of ischemia extending transmurally in long axis (a), and corresponding short axis (b). Horizontal
arrows highlight patchy, subepicardial LGE more typical of myocardial inﬂammation in long axis (a), and corresponding short axis (c).
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this was the discovery of LGE in a subendocardial (ischemic)
distribution in a small portion of patients with biopsy-proven viral
myocarditis, no signiﬁcant epicardial coronary artery stenosis, and
a positive acetylcholine challenge.
There is clearly a considerable overlap in the clinical and
laboratory ﬁndings of hypersensitivity myocarditis and Kounis
syndrome, in so much as the two clinical entities can be
inseparable on these parameters alone. An endomyocardial biopsy
can assist with diagnosis, although sampling error in a focal
process can result in a signiﬁcant false-negative rate. In our case,
the patient remained clinically stable following the initial
hypersensitivity reaction, without evidence of left ventricular
systolic dysfunction or heart failure. In this setting, robust evidence
for endomyocardial biopsy is lacking and is not recommended
under current guidelines [8].
CMR has assumed a key role in such a setting. LGE in myocardial
infarction typically extends from the subendocardial region,
corresponding to the infarct-related artery, whereas use of the
Lake Louise Criteria in myocarditis (deﬁned as two out of the
following three: edema with T2-weighted images, hyperemia
detected by EGE, and LGE in non-ischemic distribution) gives a
diagnostic accuracy of 78%, sensitivity of 67%, and speciﬁcity of 91%
[9]. In our case, there was subendocardial LGE extending
transmurally, suggesting myocardial infarction, and subepicardial
and mid-wall LGE, suggesting myocardial inﬂammation. To our
knowledge this is the ﬁrst case of presumed Kounis syndrome with
objective evidence of myocardial infarction, albeit in conjunction
with myocardial inﬂammation. We postulate that myocarditis
predisposed to coronary vasospasm, perhaps by decreasing nitric
oxide bioavailability, increasing oxidative stress, or increasing
vascular smooth muscle cell hyperreactivity [10].
In summary, Kounis syndrome is well described in the literature
and is deﬁned by myocardial ischemia in the presence of mast cell
degranulation due to allergic, anaphylactic, or anaphylactoid
reactions. Hypersensitivity myocarditis reﬂects myocardial in-
volvement of an allergic reaction, and it shares almost identical
clinical features to those described in Kounis syndrome. Endo-
myocardial biopsy has the capability to differentiate between
these entities, but it is infrequently performed in this patient group
for various reasons. CMR offers a safe and effective non-invasive
method to identify myocarditis and myocardial infarction, yetreports in Kounis syndrome are scarce. Two of the three published
cases with CMR conﬁrmed myocarditis, one of which was
subsequently proven by endomyocardial biopsy [2,3]. The third
case had insufﬁcient CMR sequences to conﬁrm myocardial
ischemia, and reported ﬁndings were more consistent with
myocarditis [4]. While our case describes the novel ﬁnding of
myocardial infarction in this clinical setting, it coexists with
myocardial inﬂammation. Given the common feature of all these
cases is myocarditis, our suspicion is that Kounis syndrome reﬂects
the sequelae of myocardial inﬂammation, rather than prima facie
myocardial ischemia. More widespread use of CMR in similar cases
would add signiﬁcantly to our limited understanding of these rare
clinical presentations.
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